LifeStance Health SG&A Expenses 2020-2024 | LFST

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

LifeStance Health sg&a expenses from 2020 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

LifeStance Health sg&a expenses from 2020 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$20.9B
Quest Diagnostics (DGX)	$16.9B
DaVita (DVA)	$13.6B
Encompass Health (EHC)	$9.5B
Chemed (CHE)	$8.3B
Elanco Animal Health (ELAN)	$5.9B
Option Care Health (OPCH)	$5B
RadNet (RDNT)	$4.4B
Amedisys (AMED)	$3B
Addus HomeCare (ADUS)	$2.4B
Astrana Health (ASTH)	$2B
U.S Physical Therapy (USPH)	$1.3B
Pennant (PNTG)	$943M
Aveanna Healthcare Holdings (AVAH)	$899M
Atai Life Sciences (ATAI)	$245M
Bioqual (BIOQ)	$58M
Daxor (DXR)	$41M
Ontrak (OTRK)	$7M
MEDIROM Healthcare Technologies (MRM)	$5M
IMAC Holdings (BACK)	$3M
Psychemedics (PMD)	$0M